Literature DB >> 28993139

Rapid quantification of glutaminase 2 (GLS2)-related metabolites by HILIC-MS/MS.

Guan-Yuan Chen1, Hsi-Chun Chao1, Hsiao-Wei Liao1, I-Lin Tsai2, Ching-Hua Kuo3.   

Abstract

Glutamine, glutamate and glutathione are key modulators of excessive oxidative stress in tumor cells. In this study, we developed a rapid and accurate HILIC-MS/MS method to simultaneously determine concentrations of cellular glutamine, glutamate and glutathione. A bared silica HILIC column was employed to analyze these polar metabolites. The LC-MS parameters were optimized to achieve high sensitivity and selectivity. The analysis can be completed within 4 min under optimal conditions. The method was validated in terms of accuracy, precision, and linearity. Intra-day (n = 9) precision was within 2.68-6.24% among QCs. Inter-day precision (n = 3) was below 12.4%. The method accuracy was evaluated by the recovery test, and the accuracy for three analytes were between 91.6 and 110%. The developed method was applied to study antioxidant function of GLS2 in non-small cell lung cancer cells. Changes in concentrations of glutamine, glutamate and glutathione revealed that the overexpression of GLS2 could effectively decrease oxidative stress. In summary, this study developed a rapid HILIC-MS/MS method for quantification of GLS2-related metabolites that could facilitate elucidation of the role of GLS2 in tumor development.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Cellular metabolites; Glutaminase 2; HILIC-MS/MS; Oxidative stress; Quantification

Mesh:

Substances:

Year:  2017        PMID: 28993139     DOI: 10.1016/j.ab.2017.10.002

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  1 in total

1.  Protective Mechanism of Gandou Decoction in a Copper-Laden Hepatolenticular Degeneration Model: In Vitro Pharmacology and Cell Metabolomics.

Authors:  Fengxia Yin; Mengnan Nian; Na Wang; Hongfei Wu; Huan Wu; Wenchen Zhao; Shijian Cao; Peng Wu; An Zhou
Journal:  Front Pharmacol       Date:  2022-03-23       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.